{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:45:49Z","timestamp":1782420349815,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovation Project of Guangxi Graduate Education","award":["YCSW2024428"],"award-info":[{"award-number":["YCSW2024428"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360937"],"award-info":[{"award-number":["82360937"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangxi Natural Science Foundation","award":["2023GXNSFAA026075"],"award-info":[{"award-number":["2023GXNSFAA026075"]}]},{"name":"Guangxi University of Chinese Medicine's Scientific Research Start-up Fund Project for Introducing Doctor","award":["2023BS042"],"award-info":[{"award-number":["2023BS042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postmenopausal osteoporosis (PMOP) is a common bone disease among middle-aged and elderly women. Ferroptosis, a form of programmed cell death, plays a crucial role in the regulation of bone metabolism. Yishen Gushu Formula (YSGSF), a traditional Chinese medicine (TCM) compound, has clinical potential for treating PMOP, yet its specific mechanism of action remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to investigate the specific mechanism by which YSGSF treats PMOP by inhibiting ferroptosis through mediating the NCOA4\/GPX4 pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The rat PMOP model was established by OVX and treated with YSGSF for 12 consecutive weeks. HE staining and micro-CT were used to examine bone tissue morphology and structure. Serum levels of E2, PINP, and \u03b2-CTX were measured by ELISA. RNA-seq analysis was performed to explore the potential mechanism of YSGSF. Oxidative stress markers (ROS, MDA, SOD, GSH, FE) in rat serum were determined. The regulatory effects of YSGSF on NCOA4, FTH1, GPX4, and SLC7A11 were evaluated by IHC and qRT-PCR. Erastin was used in vitro to induce ferroptosis in ROS17\/28 osteoblasts, with cell viability and ferroptosis-related protein levels detected by CCK8 and Western blotting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>YSGSF improved bone metabolism in OVX rats, alleviated osteoporotic morphological changes, promoted the overall structural recovery of trabecular bone, and increased bone density. RNA-seq suggested that YSGSF may exert its therapeutic effect on PMOP by inhibiting ferroptosis. Subsequent results indicated that YSGSF improved iron metabolism in bone tissue and suppressed iron-dependent oxidative damage. It reduced serum iron ion accumulation and inhibited the production of ROS and MDA. IHC and qRT-PCR confirmed that YSGSF suppressed the expression of NCOA4, upregulated FTH1, and further increased the expression levels of GPX4 and SLC7A11. In vitro cell experiments demonstrated that YSGSF ameliorates Erastin-induced ferroptosis in osteoblasts, improving the expression of related proteins and cell viability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>YSGSF ameliorates OVX-induced PMOP, potentially by inhibiting osteoblast ferroptosis through modulation of the NCOA4\/GPX4 pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00642-5","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:39:24Z","timestamp":1770201564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Yishen Gushu formula exerts osteoprotective effects in OVX-Induced PMOP rats: role of ferroptosis Inhibition and iron metabolism correction"],"prefix":"10.1186","volume":"163","author":[{"given":"Bo","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiFeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YongJin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoYun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"4","key":"642_CR1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.5534\/wjmh.200099","volume":"39","author":"M De Martinis","year":"2021","unstructured":"De Martinis M, Sirufo MM, Polsinelli M, Placidi G, Di Silvestre D, Ginaldi L. Gender differences in osteoporosis: A Single-Center observational study. World J Men\u2019s Health. 2021;39(4):750.","journal-title":"World J Men\u2019s Health"},{"issue":"1","key":"642_CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s13018-025-05714-2","volume":"20","author":"X Zhou","year":"2025","unstructured":"Zhou X, Long H, Wang J, Huang Z, Cao L. Clinical outcomes and safety of combined calcitriol and bisphosphonates in treating postmenopausal osteoporosis: a retrospective cohort study. J ORTHOP SURG RES. 2025;20(1):359.","journal-title":"J ORTHOP SURG RES"},{"issue":"9","key":"642_CR3","first-page":"e290289","volume":"18","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang Z, Zhang D, Ye D, Zhou Y, Qin J, et al. The prevalence and treatment rate trends of osteoporosis in postmenopausal women. PLoS ONE. 2023;18(9):e290289.","journal-title":"PLoS ONE"},{"key":"642_CR4","doi-asserted-by":"crossref","first-page":"105757","DOI":"10.1016\/j.humpath.2025.105757","volume":"157","author":"F Viehweger","year":"2025","unstructured":"Viehweger F, Gusinde J, Leege N, Tinger L, Gorbokon N, Menz A, et al. Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entities. HUM PATHOL. 2025;157:105757.","journal-title":"HUM PATHOL"},{"issue":"7","key":"642_CR5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2165\/00003495-200161070-00010","volume":"61","author":"M Sharpe","year":"2001","unstructured":"Sharpe M, Noble S, Spencer CM. Alendronate DRUGS. 2001;61(7):999\u20131039.","journal-title":"Alendronate DRUGS"},{"issue":"4","key":"642_CR6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","volume":"32","author":"JL Vahle","year":"2004","unstructured":"Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M. Bone neoplasms in F344 rats given teriparatide [rhPTH(1\u201334)] are dependent on duration of treatment and dose. TOXICOL PATHOL. 2004;32(4):426\u201338.","journal-title":"TOXICOL PATHOL"},{"key":"642_CR7","doi-asserted-by":"crossref","first-page":"154768","DOI":"10.1016\/j.phymed.2023.154768","volume":"114","author":"C Guo","year":"2023","unstructured":"Guo C, Huang Q, Wang Y, Yao Y, Li J, Chen J, et al. Therapeutic application of natural products: NAD\u2009+\u2009metabolism as potential target. Phytomedicine. 2023;114:154768.","journal-title":"Phytomedicine"},{"issue":"4","key":"642_CR8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/biology14040367","volume":"14","author":"P Li","year":"2025","unstructured":"Li P, Xu T, Yu A, Liang J, Zhou Y, Sun H, et al. The role of ferroptosis in osteoporosis and advances in Chinese herbal interventions. Biology. 2025;14(4):367.","journal-title":"Biology"},{"key":"642_CR9","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3389\/fphar.2019.00988","volume":"10","author":"N Wang","year":"2019","unstructured":"Wang N, Xin H, Xu P, Yu Z, Shou D. Erxian Decoction attenuates TNF-\u03b1 induced osteoblast apoptosis by modulating the Akt\/Nrf2\/HO-1 signaling pathway. FRONT PHARMACOL. 2019;10:988.","journal-title":"FRONT PHARMACOL"},{"key":"642_CR10","doi-asserted-by":"crossref","first-page":"155257","DOI":"10.1016\/j.phymed.2023.155257","volume":"123","author":"B Li","year":"2024","unstructured":"Li B, Chen Z, Zhang Z, Liu H, Han D, Yang H, et al. Zuogui pill disrupt the malignant cycle in breast cancer bone metastasis through the Piezo1-Notch-1-GPX4 pathway and active molecules fishing. Phytomedicine. 2024;123:155257.","journal-title":"Phytomedicine"},{"issue":"46","key":"642_CR11","doi-asserted-by":"crossref","first-page":"25586","DOI":"10.1021\/acs.jafc.4c05370","volume":"72","author":"S Cao","year":"2024","unstructured":"Cao S, Wang Y, Zhang Y, Ren J, Fan B, Deng Y, et al. Naringenin can inhibit the pyroptosis of osteoblasts by activating the Nrf2\/HO-1 signaling pathway and alleviate the differentiation disorder of osteoblasts caused by microgravity. J AGR FOOD CHEM. 2024;72(46):25586\u2013600.","journal-title":"J AGR FOOD CHEM"},{"key":"642_CR12","doi-asserted-by":"crossref","first-page":"109676","DOI":"10.1016\/j.biopha.2019.109676","volume":"121","author":"W Jin","year":"2020","unstructured":"Jin W, Zhu X, Yao F, Xu X, Chen X, Luo Z, et al. Cytoprotective effect of Fufang Lurong Jiangu capsule against hydrogen peroxide-induced oxidative stress in bone marrow stromal cell-derived osteoblasts through the Nrf2\/HO-1 signaling pathway. BIOMED PHARMACOTHER. 2020;121:109676.","journal-title":"BIOMED PHARMACOTHER"},{"key":"642_CR13","doi-asserted-by":"crossref","first-page":"902102","DOI":"10.3389\/fphar.2022.902102","volume":"13","author":"J Hao","year":"2022","unstructured":"Hao J, Bei J, Li Z, Han M, Ma B, Ma P, et al. Qing`e pill inhibits osteoblast ferroptosis via ATM Serine\/Threonine kinase (ATM) and the PI3K\/AKT pathway in primary osteoporosis. FRONT PHARMACOL. 2022;13:902102.","journal-title":"FRONT PHARMACOL"},{"issue":"12","key":"642_CR14","doi-asserted-by":"crossref","first-page":"2307388","DOI":"10.1002\/advs.202307388","volume":"11","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Qi G, He X, Yu Y, Cao Y, Zhang C, et al. Ferroptosis in osteocytes as a target for protection against postmenopausal osteoporosis. ADV SCI. 2024;11(12):2307388.","journal-title":"ADV SCI"},{"key":"642_CR15","doi-asserted-by":"crossref","first-page":"833474","DOI":"10.3389\/fendo.2021.833474","volume":"12","author":"X Wei","year":"2022","unstructured":"Wei X, Qi B, Ma R, Zhang Y, Liu N, Fang S, et al. Quantitative proteomics revealed the pharmacodynamic network of Bugu Shengsui Decoction promoting osteoblast proliferation. FRONT ENDOCRINOL. 2022;12:833474.","journal-title":"FRONT ENDOCRINOL"},{"key":"642_CR16","doi-asserted-by":"crossref","first-page":"654714","DOI":"10.3389\/fphar.2021.654714","volume":"12","author":"H Xia","year":"2021","unstructured":"Xia H, Liu J, Yang W, Liu M, Luo Y, Yang Z, et al. Integrated strategy of network Pharmacological prediction and experimental validation elucidate possible mechanism of Bu-Yang herbs in treating postmenopausal osteoporosis via ESR1. FRONT PHARMACOL. 2021;12:654714.","journal-title":"FRONT PHARMACOL"},{"issue":"1","key":"642_CR17","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41467-025-55929-4","volume":"16","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Gong H, Jiang M, Jin F, Wang G, Yan C, et al. Regulation of enzymatic lipid peroxidation in osteoblasts protects against postmenopausal osteoporosis. NAT COMMUN. 2025;16(1):758.","journal-title":"NAT COMMUN"},{"issue":"2","key":"642_CR18","doi-asserted-by":"crossref","first-page":"101581","DOI":"10.1016\/j.jocd.2025.101581","volume":"28","author":"X Zhong","year":"2025","unstructured":"Zhong X, Li L, Wan W. Optimal kidney-tonifying traditional Chinese medicines for postmenopausal osteoporosis: A network meta-analysis of randomized controlled trials. J CLIN DENSITOM. 2025;28(2):101581.","journal-title":"J CLIN DENSITOM"},{"key":"642_CR19","doi-asserted-by":"crossref","unstructured":"Li Y, Li Y, Li P, Yang L, Li H. 4-Octyl Itaconate Attenuates Postmenopausal Osteoporosis by Inhibiting Ferroptosis and Enhancing Osteogenesis via the Nrf2 Pathway. INFLAMMATION. 2025;48(5):3326\u201339.","DOI":"10.1007\/s10753-025-02268-7"},{"issue":"2","key":"642_CR20","doi-asserted-by":"crossref","first-page":"e70288","DOI":"10.1111\/jcmm.70288","volume":"29","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Sun R, Yang H, Gu T, Han M, Yu C, et al. Aucubin PromotesBMSCs proliferation and differentiation of postmenopausal osteoporosis patients by regulating ferroptosis andBMP2 signalling. J CELL MOL MED. 2025;29(2):e70288.","journal-title":"J CELL MOL MED"},{"issue":"18","key":"642_CR21","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.18632\/aging.204945","volume":"15","author":"Z Cao","year":"2023","unstructured":"Cao Z, Xue Y, Wang J. Screening diagnostic markers of osteoporosis based on ferroptosis of osteoblast and osteoclast. Aging. 2023;15(18):9391\u2013407.","journal-title":"Aging"},{"key":"642_CR22","doi-asserted-by":"crossref","first-page":"986384","DOI":"10.3389\/fendo.2022.986384","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Han J, Ding S, Liu S, Wang H. Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis. FRONT ENDOCRINOL. 2022;13:986384.","journal-title":"FRONT ENDOCRINOL"},{"issue":"1","key":"642_CR23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12920-023-01779-2","volume":"17","author":"Z Li","year":"2024","unstructured":"Li Z, Xu J, Shi S, Weng Y, Guo B, Che L, et al. Identification and validation of iron metabolism genes in osteoporosis. BMC MED GENOMICS. 2024;17(1):5.","journal-title":"BMC MED GENOMICS"},{"issue":"1","key":"642_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12920-024-01872-0","volume":"17","author":"S Long","year":"2024","unstructured":"Long S, Li S, Li J, He Y, Tan B, Jing H, et al. Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular Docking technology. BMC MED GENOMICS. 2024;17(1):99.","journal-title":"BMC MED GENOMICS"},{"key":"642_CR25","doi-asserted-by":"crossref","first-page":"103195","DOI":"10.1016\/j.redox.2024.103195","volume":"73","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang J, Tian Y, Xu X, Wang B, Huang Z, et al. Iron accumulation in ovarian microenvironment damages the local redox balance and oocyte quality in aging mice. REDOX BIOL. 2024;73:103195.","journal-title":"REDOX BIOL"},{"issue":"1","key":"642_CR26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00018-025-05695-9","volume":"82","author":"A Conjard-Duplany","year":"2025","unstructured":"Conjard-Duplany A, Osseni A, Lamboux A, Mouradian S, Picard F, Moncollin V, et al. Muscle mTOR controls iron homeostasis and ferritinophagy via NRF2, HIFs and AKT\/PKB signaling pathways. CELL MOL LIFE SCI. 2025;82(1):178.","journal-title":"CELL MOL LIFE SCI"},{"issue":"1","key":"642_CR27","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1038\/s41598-025-86333-z","volume":"15","author":"N Honari","year":"2025","unstructured":"Honari N, Sayadi M, Sajjadi SM, Solhjoo S, Sarab GA. Deferasirox improved iron homeostasis and hematopoiesis in ovariectomized rats with iron accumulation. SCI REP-UK. 2025;15(1):2449.","journal-title":"SCI REP-UK"},{"issue":"11","key":"642_CR28","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3390\/nu15112461","volume":"15","author":"P Lin","year":"2023","unstructured":"Lin P, Su W, Li C, Lin L, Sheu J, Wen Z, et al. Investigating the Role of Ferroptosis-Related Genes in Ovarian Aging and the Potential for Nutritional Intervention. NUTRIENTS. 2023;15(11):2461.","journal-title":"Nutrients"},{"key":"642_CR29","first-page":"110213","volume":"295","author":"Y Gao","year":"2025","unstructured":"Gao Y, Chen H, Lian H, Cai X, Xie L, Ahmed RG, et al. The role of the ferroptosis pathway in the toxic mechanism of TCDD-induced liver damage in zebrafish. Comp Biochem Physiol C: Toxicol Pharmacol. 2025;295:110213.","journal-title":"Comp Biochem Physiol C: Toxicol Pharmacol"},{"issue":"3","key":"642_CR30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3892\/ol.2022.13224","volume":"23","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li C, Zhang Y, Zhang J, Yang X. Ophiopogonin B induces gastric cancer cell death by blocking the GPX4\/xCT\u2013dependent ferroptosis pathway. ONCOL LETT. 2022;23(3):104.","journal-title":"ONCOL LETT"},{"issue":"5","key":"642_CR31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3390\/ijms26052027","volume":"26","author":"S Chen","year":"2025","unstructured":"Chen S, Xiao J, Zhou S, Wumiti T, Zhao Z, Zhao R et al. (2025). The GPR30-Mediated BMP-6\/HEP\/FPN Signaling Pathway Inhibits Ferroptosis in Bone Marrow Mesenchymal Stem Cells to Alleviate Osteoporosis. International Journal of Molecular Sciences 26(5): 2027.","journal-title":"Int J Mol Sci"},{"key":"642_CR32","doi-asserted-by":"crossref","first-page":"100863","DOI":"10.1016\/j.diff.2025.100863","volume":"143","author":"D Ke","year":"2025","unstructured":"Ke D, Gao T, Dai H, Xu J, Ke T. RANKL promotes MT2 degradation and ROS production in osteoclast precursors through Beclin1-dependent autophagy. DIFFERENTIATION. 2025;143:100863.","journal-title":"DIFFERENTIATION"},{"issue":"6","key":"642_CR33","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/jor.26075","volume":"43","author":"I Shinohara","year":"2025","unstructured":"Shinohara I, Morita M, Chow SKH, Murayama M, Sususki Y, Gao Q, et al. Pathophysiology of the effects of oxidative stress on the skeletal system. J ORTHOP RES. 2025;43(6):1059\u201372.","journal-title":"J ORTHOP RES"},{"key":"642_CR34","doi-asserted-by":"crossref","first-page":"1548491","DOI":"10.3389\/fphar.2025.1548491","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang H, Huang Z, Chen G, Li Y, Liu Y, Gu H, et al. Astragaloside IV alleviated bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and fecal metabolism. FRONT PHARMACOL. 2025;16:1548491.","journal-title":"FRONT PHARMACOL"},{"issue":"5","key":"642_CR35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/antiox14050605","volume":"14","author":"H Zhao","year":"2025","unstructured":"Zhao H, Yu F, Wu W. New perspectives on postmenopausal osteoporosis: mechanisms and potential therapeutic strategies of sirtuins and oxidative stress. ANTIOXIDANTS-BASEL. 2025;14(5):605.","journal-title":"ANTIOXIDANTS-BASEL"},{"key":"642_CR36","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.2147\/JIR.S432111","volume":"16","author":"H Chen","year":"2023","unstructured":"Chen H, Han Z, Wang Y, Su J, Lin Y, Cheng X, et al. Targeting ferroptosis in Bone-Related diseases: facts and perspectives. J INFLAMM RES. 2023;16:4661\u201377.","journal-title":"J INFLAMM RES"},{"key":"642_CR37","doi-asserted-by":"crossref","first-page":"118469","DOI":"10.1016\/j.jep.2024.118469","volume":"333","author":"H Liu","year":"2024","unstructured":"Liu H, Zhang C, Chai Y, Zhou Y, Zeng H, Zhang X. Using broadly targeted plant metabolomics technology combined with network Pharmacology to explore the mechanism of action of the Yishen Gushu formula in the treatment of postmenopausal osteoporosis in vivo. J ETHNOPHARMACOL. 2024;333:118469.","journal-title":"J ETHNOPHARMACOL"},{"key":"642_CR38","doi-asserted-by":"crossref","first-page":"101648","DOI":"10.1016\/j.mtbio.2025.101648","volume":"32","author":"T Li","year":"2025","unstructured":"Li T, Zhao J, Yuan J, Ding R, Yang G, Cao J, et al. Harnessing engineered exosomes as METTL3 carriers: enhancing osteogenesis and suppressing lipogenesis in bone marrow mesenchymal stem cells for postmenopausal osteoporosis treatment. MATER TODAY BIO. 2025;32:101648.","journal-title":"MATER TODAY BIO"},{"issue":"1","key":"642_CR39","doi-asserted-by":"crossref","first-page":"2492378","DOI":"10.1080\/19490976.2025.2492378","volume":"17","author":"L Sapra","year":"2025","unstructured":"Sapra L, Saini C, Mishra PK, Garg B, Gupta S, Manhas V, et al. Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the Gut-Immune-Bone axis. Gut Microbes. 2025;17(1):2492378.","journal-title":"Gut Microbes"},{"issue":"2","key":"642_CR40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/antiox14020197","volume":"14","author":"G Hu","year":"2025","unstructured":"Hu G, Whitaker AL, Zhang G, Karner CM. Divergent requirements for glutathione biosynthesis during osteoclast differentiation in vitro and in vivo. ANTIOXIDANTS-BASEL. 2025;14(2):197.","journal-title":"ANTIOXIDANTS-BASEL"},{"issue":"7","key":"642_CR41","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.3390\/ijms26072949","volume":"26","author":"C Tipbunjong","year":"2025","unstructured":"Tipbunjong C, Khimmaktong W, Hengpratom T, Thitiphatphuvanon T, Pholpramool C, Surinlert P. Glabridin alleviates oxidative Stress-Induced osteoporosis by targeting the Akt\/NF-\u0138B and Akt\/GSK-3\u03b2 pathways. Int J Mol Sci. 2025;26(7):2949.","journal-title":"Int J Mol Sci"},{"key":"642_CR42","doi-asserted-by":"crossref","unstructured":"Ouyang J, Chai H, Sun C, Wang S, She C, Geng D et al. Titanium particles activate osteocytic connexin 43 to induce oxidative stress and osteoclastogenesis through the JAK-STAT pathway. ANTIOXID REDOX SIGN: 2024\u2013894. ANTIOXIDANTS& REDOX SIGNALING. 2025;43(4-6):215\u2013238.","DOI":"10.1089\/ars.2024.0894"},{"issue":"1","key":"642_CR43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11914-025-00914-5","volume":"23","author":"R Tao","year":"2025","unstructured":"Tao R, Qiao M, Wang B, Fan J, Gao F, Wang S, et al. Laboratory-based biomarkers for risk Prediction, auxiliary diagnosis and Post-operative Follow-up of osteoporotic fractures. CURR OSTEOPOROS REP. 2025;23(1):19.","journal-title":"CURR OSTEOPOROS REP"},{"key":"642_CR44","doi-asserted-by":"crossref","first-page":"117345","DOI":"10.1016\/j.taap.2025.117345","volume":"500","author":"Y Fan","year":"2025","unstructured":"Fan Y, Yu Y, Yan P. The protective effects of tectoridin on bone fractures against oxidative stress via the Inhibition of NF-\u03baB and apoptotic pathways in ovariectomized rats. TOXICOL APPL PHARM. 2025;500:117345.","journal-title":"TOXICOL APPL PHARM"},{"issue":"02","key":"642_CR45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1142\/S0192415X25500156","volume":"53","author":"D Lan","year":"2025","unstructured":"Lan D, Huang S, Li J, Zhou S, Deng J, Qin S, et al. Ferroptosis in endometriosis: traditional Chinese medicine interventions and mechanistic insights. Am J Chin Med. 2025;53(02):385\u2013408.","journal-title":"Am J Chin Med"},{"issue":"7","key":"642_CR46","doi-asserted-by":"crossref","first-page":"e22985","DOI":"10.1096\/fj.202202131RR","volume":"37","author":"H Lv","year":"2023","unstructured":"Lv H, Wang Y, Zhen C, Liu J, Chen X, Zhang G, et al. A static magnetic field improves bone quality and balances the function of bone cells with regulation on iron metabolism and redox status in type 1 diabetes. FASEB J. 2023;37(7):e22985.","journal-title":"FASEB J"},{"key":"642_CR47","doi-asserted-by":"crossref","first-page":"102922","DOI":"10.1016\/j.redox.2023.102922","volume":"67","author":"Z Jing","year":"2023","unstructured":"Jing Z, Li Y, Zhang H, Chen T, Yu J, Xu X, et al. Tobacco toxins induce osteoporosis through ferroptosis. REDOX BIOL. 2023;67:102922.","journal-title":"REDOX BIOL"},{"key":"642_CR48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.freeradbiomed.2021.04.027","volume":"169","author":"S Ni","year":"2021","unstructured":"Ni S, Yuan Y, Qian Z, Zhong Z, Lv T, Kuang Y, et al. Hypoxia inhibits RANKL-induced ferritinophagy and protects osteoclasts from ferroptosis. FREE RADICAL BIO MED. 2021;169:271\u201382.","journal-title":"FREE RADICAL BIO MED"},{"key":"642_CR49","doi-asserted-by":"crossref","first-page":"115339","DOI":"10.1016\/j.biopha.2023.115339","volume":"166","author":"Z Liu","year":"2023","unstructured":"Liu Z, Xi X, Wu T, Lu Y, Zhong P, Hu Y, et al. Aikeqing, a kidney- and spleen-tonifying compound Chinese medicine granule, prevented ovariectomy-induced bone loss in rats via the suppression of osteoclastogenesis. BIOMED PHARMACOTHER. 2023;166:115339.","journal-title":"BIOMED PHARMACOTHER"},{"key":"642_CR50","doi-asserted-by":"crossref","first-page":"116211","DOI":"10.1016\/j.jpba.2024.116211","volume":"246","author":"G Shang","year":"2024","unstructured":"Shang G, Zhou X, Yin J, Niu X, Zhao Y, Li X, et al. Multi-omics analysis of kidney, bone and bone marrow explored potential mechanisms of Erzhi Wan against osteoporosis with kidney-Yin deficiency. J PHARMACEUT BIOMED. 2024;246:116211.","journal-title":"J PHARMACEUT BIOMED"},{"issue":"3","key":"642_CR51","first-page":"489","volume":"44","author":"F Yanchen","year":"2024","unstructured":"Yanchen F, Yali L, Xue D, Zixuan L, Yunke Z, Zhiying C, et al. Exploring the multicomponent synergy mechanism of Zuogui Wan on postmenopausal osteoporosis by a systems Pharmacology strategy. J TRADIT CHIN MED. 2024;44(3):489\u201395.","journal-title":"J TRADIT CHIN MED"},{"key":"642_CR52","doi-asserted-by":"crossref","first-page":"119710","DOI":"10.1016\/j.jep.2025.119710","volume":"346","author":"X Li","year":"2025","unstructured":"Li X, Wang Z, Chen Y, Yang Y, Shao H, Feng X, et al. Regulation of monocyte polarization through nuclear factor kappa B \/inhibitor of kappa B alpha pathway by cuscuta chinensis Lam. In postmenopausal osteoporosis. J ETHNOPHARMACOL. 2025;346:119710.","journal-title":"J ETHNOPHARMACOL"},{"key":"642_CR53","doi-asserted-by":"crossref","first-page":"119549","DOI":"10.1016\/j.jep.2025.119549","volume":"344","author":"B Luo","year":"2025","unstructured":"Luo B, Liang Z, Lin W, Li Y, Zhong W, Bai D, et al. Aqueous extract of rehmanniae radix praeparata improves bone health in ovariectomized rats by modulating the miR-29a-3p\/NFIA\/Wnt signaling pathway axis. J ETHNOPHARMACOL. 2025;344:119549.","journal-title":"J ETHNOPHARMACOL"},{"issue":"1","key":"642_CR54","doi-asserted-by":"crossref","first-page":"e4604","DOI":"10.1002\/fsn3.4604","volume":"13","author":"L Zhu","year":"2025","unstructured":"Zhu L, Wang Y, Zhu Z, Yao X, Zhang R, Xia Y, et al. Selection of the Anti-Osteoporosis active ingredients of fructus Psoraleae\u2014Eucommia\u2014Drynariae rhizoma based on Solid\u2010Phase Bio\u2010Cell chromatography AndHPLC \u2013MS analysis. FOOD SCI NUTR. 2025;13(1):e4604.","journal-title":"FOOD SCI NUTR"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00642-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:04:49Z","timestamp":1781651089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00642-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00642-5","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal experimental protocol has been reviewed and approved by the Experimental Animal Ethics Committee of Guangxi University of Chinese Medicine, with the ethical approval number: DW20231109-234.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript and agree to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}